Evidence map›Paper›PMID 39330281›Full record

ArticleMarine drugs2024

Novel Galectins Purified from the Sponge

Ryuhei Hayashi, Kenichi Kamata, Marco Gerdol, Yuki Fujii, Takashi Hayashi, Yuto Onoda, Nanae Kobayashi, Satoshi Furushima, Ryuya Ishiwata, Mayuka Ohkawa and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Afil, a Lectin fromMicroorganisms · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Ryuhei HayashiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Kenichi KamataDepartment of Chemistry, KU Leuven, 3001 Heverlee, Belgium.ORCID 0000-0003-4344-8473
Marco GerdolDepartment of Life Sciences, University of Trieste, Via Licio Giorgieri 5, 34127 Trieste, Italy.ORCID 0000-0001-6411-0813
Yuki FujiiGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.ORCID 0000-0001-6408-9620
Takashi HayashiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Yuto OnodaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Nanae KobayashiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Satoshi FurushimaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Ryuya IshiwataGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Mayuka OhkawaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Naoko MasudaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Yuka NiimiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Masao YamadaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Daisuke AdachiGraduate School of Biomedical Sciences, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
Sarkar M A KawsarDepartment of Chemistry, Faculty of Science, University of Chittagong, Chittagong 4331, Bangladesh.ORCID 0000-0001-7964-9117
Sultana RajiaCenter for Interdisciplinary Research, Varendra University, Rajshahi 6204, Bangladesh.
Imtiaj HasanDepartment of Microbiology, Faculty of Biological Science, University of Rajshahi, Rajshahi 6205, Bangladesh.ORCID 0000-0002-4715-9022
Somrita PadmaDepartment of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata 700026, India.ORCID 0000-0001-5698-6604
Bishnu Pada ChatterjeeDepartment of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata 700026, India.
Yuji IseKuroshio Biological Research Foundation, 560 Nishidomar, Otsuki, Hata, Kochi 788-0333, Japan.ORCID 0009-0009-4887-611X
Riku ChidaGraduate School of Food and Nutritional Sciences, Toyo University, 48-1, Oka, Asaka, Saitama 351-8510, Japan.
Kayo HasehiraGraduate School of Food and Nutritional Sciences, Toyo University, 48-1, Oka, Asaka, Saitama 351-8510, Japan.
Nobumitsu MiyanishiGraduate School of Food and Nutritional Sciences, Toyo University, 48-1, Oka, Asaka, Saitama 351-8510, Japan.ORCID 0000-0001-9632-7195
Tatsuya KawasakiGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.ORCID 0000-0002-5991-6174
Yukiko OgawaGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.
Hideaki FujitaGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.ORCID 0000-0002-4105-4430
Alberto PallaviciniDepartment of Life Sciences, University of Trieste, Via Licio Giorgieri 5, 34127 Trieste, Italy.ORCID 0000-0001-7174-4603
Yasuhiro OzekiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.ORCID 0000-0002-2782-6158

Funding

Japan Society for the Promotion of Science 23K06190Japan Society for the Promotion of Science 23K10950Japan Society for the Promotion of Science 24K06239Japan Society for the Promotion of Science 24K15170J-GlycoNet FY2024_E-26The European Union Next-GenerationEU (PIANO NAZIONALE DI RIPRESA E RESILIENZA (PNRR) - MISSIONE 4 COMPONENTE 2, INVESTIMENTO 1.5 D.D. 1058 23/06/2022, ECS00000043Yokohama Trial Grant for Research and Development YT2024-1050
6 · The paper itself

Abstract

We here report the purification of a novel member of the galectin family, the β-galactoside-binding lectin hRTL, from the marine sponge

Indexed as

Antigens, Tumor-Associated, CarbohydrateColorectal NeoplasmsGalectinsAmino Acid SequenceAmino SugarsAnimalsAntineoplastic AgentsCell Line, TumorHumansPoriferaAmino SugarsAntigens, Tumor-Associated, CarbohydrateAntineoplastic AgentsGalectinsN-acetyllactosamineThomsen-Friedenreich antigenChondrilla australiensiscytotoxicitygalectinPoriferasignal peptideTF-antigen

Identifiers

PMID39330281
PMCPMC11433124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.